Hide filtersShow filters × Close Bryan, Garnier & Co announces the success of the IPO of Erytech with a Capital Increase of €28 Million Bryan, Garnier & Co acts as joint bookrunner for a €45 million private placement for Ablynx Bryan, Garnier & Co advised Mérieux NutriSciences in the acquisition of Chelab Bryan, Garnier & Co has advised FSI on EUR 15 million investment in DBV Technologies Bryan, Garnier & Co advised Biomain AB in sale to Heraeus Group Bryan, Garnier and Co advised Santen Pharmaceutical Co. Ltd. on its successful takeover of Novagali Pharma S.A. Bryan, Garnier & Co advises Cellectis on its acquisition of Cellartis and EUR 50 million capital increase €8 million capital raising for PVP Laboratoires SEBBIN Funding led by new investors VENTECH, Idinvest Partners and Sigma Gestion Bryan, Garnier & Co advised bioMérieux in the acquisition of AES Laboratoire Bryan, Garnier & Co advises Silliker on its disposal of Dr. A. Verwey Success of the initial public offering of Zealand Pharma Bryan, Garnier & Co advised Synthetech in its sale to W. R. Grace & Co
